Search Results for keywords:"Health and Human Services"

The Centers for Disease Control and Prevention (CDC) is inviting public comment on a proposed study, as per the Paperwork Reduction Act of 1995, aimed at improving HIV diagnosis and care services using Point-of-Care Nucleic Acid Tests (NATs). This study, known as the Greater Access and Impact with NAT (GAIN) Study, seeks to identify challenges and supportive factors in implementing these tests in clinical settings and assess their effectiveness in speeding up HIV prevention and care. Public comments are invited until March 10, 2025, and the CDC is asking for insights on the necessity, accuracy, and cost-effectiveness of the data collection process associated with this study.

The Administration for Children and Families within the U.S. Department of Health and Human Services has withdrawn a proposed rule concerning the Temporary Assistance for Needy Families (TANF) program. Originally proposed on October 2, 2023, the rule aimed to update TANF regulations, including defining "needy," clarifying allowable expenditures, and aligning holidays with Federal standards. After receiving over 7,000 comments, the department decided they need more public input and are focusing on other priorities, such as implementing the TANF provisions of the Fiscal Responsibility Act of 2023. Thus, the proposed rule has been officially withdrawn as of January 14, 2025.

The Food and Drug Administration (FDA) is asking the public to comment on its proposed updates to how it collects information from tobacco product establishments. These changes aim to streamline the registration and listing process for such establishments and involve revisions to forms and the use of an improved electronic portal. The updates are also expected to make the registration process simpler and more efficient. The public can submit their comments online or through mail until March 18, 2025.

The Food and Drug Administration (FDA) has released a draft report titled "Best Practices for FDA Communication with Interested Parties" and is asking for public feedback. This report is part of a response to the Consolidated Appropriations Act of 2023, which requires the FDA to review and improve its communication methods with medical product sponsors and other external parties. The draft includes current communication practices and explores new, innovative strategies used during the COVID-19 pandemic. People can provide feedback on this draft report until February 3, 2025, through electronic or written submissions.

The Administration for Community Living (ACL) has submitted a proposal to the Office of Management and Budget (OMB) for the collection of information required under the Paperwork Reduction Act. This involves gathering data on the Independent Living Services Program Performance Report, which helps improve independent living services in various U.S. regions, including states, territories, and commonwealths. The ACL uses this data to ensure compliance with federal regulations and to identify training needs for organizations involved. The public can submit comments on this proposal until March 29, 2021.

The Food and Drug Administration (FDA) is seeking public comments on a proposal to gather information related to the use of public human genetic variant databases. These databases are used to support the clinical validity of genetic and genomic-based tests. The FDA is considering extending their guidelines and processes for recognizing these databases as trustworthy sources of scientific evidence. The deadline for submitting comments is March 26, 2021, and interested parties can access the collection of information online and share their feedback.

The Interagency Autism Coordinating Committee (IACC) will hold a virtual meeting on January 14, 2025, from 2:00 p.m. to 4:00 p.m., to discuss nominations for the 2024 IACC Summary of Advances in Autism Research report. This meeting is open to the public and free of charge, with advanced registration recommended via the IACC website. Closed Captioning will be available, and special accommodations can be requested at least seven days prior to the meeting. Participants can submit written comments or requests for accommodation to the contact person listed in the announcement.

The U.S. Department of Health and Human Services has announced a public meeting of the Advisory Committee on Minority Health (ACMH) on January 29, 2021. The meeting will focus on finalizing recommendations to improve access to preventive health services for minority groups. It will be held virtually, and preregistration is required to attend or submit comments. The public can find more information and register through the Office of Minority Health website.

The Department of Health and Human Services (HHS) issued a final rule amending its Uniform Administrative Requirements to realign with statutory nondiscrimination provisions stated by Congress, thus significantly altering previous regulations. This rule focuses on requiring recipients of HHS awards to adhere to applicable federal statutory nondiscrimination laws and ensures compliance with relevant Supreme Court decisions. The action also addresses concerns that previous rules might violate the Religious Freedom Restoration Act (RFRA) by causing undue burdens on religious organizations. This change aims to provide clarity and stability for grantees, while planning to avoid issues related to RFRA compliance.

The Centers for Disease Control and Prevention (CDC) has submitted a request to the Office of Management and Budget for approval to collect information under the CDC Diabetes Prevention Recognition Program (DPRP). This follows a previous notice seeking public comments, to which CDC responded with significant feedback. The proposed changes include updates to data collection methods and requirements, such as collecting optional Hemoglobin A1C levels and combining weight and physical activity metrics. The goal is to improve the program's effectiveness while reducing administrative burdens. The CDC is seeking approval for the next three years and emphasizes that participation is voluntary and data is collected in a non-identified way.